Aberrant activation of the JAK/STAT pathway was characterized to play fundamental roles in the etiology and progression of multiple human diseases, including a number of cancers; it was under intensive investigation and development for its potential as a therapeutic target. The gene discussed is SOAT1; the disease is cancer.